Get the Stockscreener App
0.231
0.00%
0.00
Genprex Inc stock is traded at $0.231, with a volume of 1.16M.
It is up +0.00% in the last 24 hours and down -13.48% over the past month.
Genprex Inc is a clinical-stage gene therapy company focused on developing life-changing therapies for patients with cancer and diabetes. Its technologies are designed to administer disease-fighting genes to provide new therapies for large patient populations with cancer and diabetes who currently have limited treatment options. Genprex's oncology program utilizes its systemic, non-viral Oncoprex Delivery System which encapsulates the gene-expressing plasmids using lipid-based nanoparticles in a lipoplex form. The company's product candidate, Reqorsa Immunogene Therapy (quaratusugene ozeplasmid), is being evaluated in three clinical trials as a treatment for NSCLC and SCLC.
See More
Previous Close:
$0.231
Open:
$0.2333
24h Volume:
1.16M
Relative Volume:
0.55
Market Cap:
$7.66M
Revenue:
-
Net Income/Loss:
$-22.71M
P/E Ratio:
-0.0197
EPS:
-11.71
Net Cash Flow:
$-18.24M
1W Performance:
-15.20%
1M Performance:
-13.48%
6M Performance:
-62.66%
1Y Performance:
-86.25%
1-Day Range:
$0.22
$0.2359
1-Week Range:
$0.22
$0.272
52-Week Range:
$0.2023
$3.97
Genprex Inc Stock (GNPX) Company Profile
Name
Genprex Inc
Sector
Industry
Phone
512-537-7997
Address
1601 TRINITY STREET, BLDG. B, AUSTIN, TX
Compare GNPX with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
GNPX
Genprex Inc
|
0.231 | 7.73M | 0 | -22.71M | -18.24M | -11.71 |
|
VRTX
Vertex Pharmaceuticals Inc
|
462.13 | 117.32B | 11.10B | -988.90M | -1.26B | -3.92 |
|
REGN
Regeneron Pharmaceuticals Inc
|
558.87 | 58.89B | 14.09B | 4.50B | 2.96B | 39.28 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
401.80 | 51.14B | 2.35B | -269.70M | -75.39M | -2.09 |
|
ARGX
Argen X Se Adr
|
673.80 | 41.02B | 2.58B | 1.06B | -1.28B | 16.33 |
|
ONC
Beone Medicines Ltd Adr
|
299.01 | 32.59B | 3.81B | -644.79M | -669.77M | -6.24 |
Genprex Inc Stock (GNPX) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Jan-26-21 | Initiated | National Securities | Buy |
| Apr-29-19 | Initiated | Noble Capital Markets | Outperform |
Genprex Inc Stock (GNPX) Latest News
How to build a custom watchlist for Genprex Inc.ROI Prediction from Long-Term Holding Plans - Newser
Price action breakdown for Genprex Inc.Weekly Return Plan for Conservative Traders - Newser
Will Genprex Inc. stock benefit from interest rate changesFree Daily Volume Spike Trading Signals - Newser
Is this a good reentry point in Genprex Inc.Alpha Generation Strategy with Low Volatility - Newser
When is Genprex Inc. stock expected to show significant growthEarnings Report Insights To Watch Now - jammulinksnews.com
What makes Genprex Inc. stock price move sharplyStable Growth Stock Overview - beatles.ru
Applying chart zones and confluence areas to Genprex Inc.Pre-Market Stock Movement Summary and Review - Newser
Relative strength of Genprex Inc. in sector analysisROI Focused Watchlist with Trade Confidence - Newser
Multi factor analysis applied to Genprex Inc.Free Oversold Bounce Stock Play Ideas - Newser
Is Genprex Inc. stock reversal real or fakeFree Entry Zone Strategy for Consistent Profit - Newser
Genprex (GNPX) to Release Quarterly Earnings on Friday - Defense World
Is Genprex Inc. forming a reversal patternAI Risk Optimized Trade Forecast Planner - Newser
Is Genprex Inc. stock overvalued or undervaluedChart Pattern Growth Plan For Smart Trading - jammulinksnews.com
Does Genprex Inc. stock perform well during market downturnsExpert Picks Tracker For Beginners - jammulinksnews.com
Genprex Inc: Weathering Stock Market Storms with 7.85M Market Cap - investchronicle.com
Technical analysis overview for Genprex Inc. stockAI-Powered Stock Trend Movement Analysis - Newser
Genprex Inc. stock trend forecastDaily Profit Watch With Forecast Confidence - Newser
What are the latest earnings results for Genprex Inc.Expert Picks Outlook From AI Tools - jammulinksnews.com
Why Genprex Inc. stock attracts strong analyst attentionFundamental + Technical Hybrid Stock Tips Shared - beatles.ru
Genprex Inc. At Decision Level — Rebound or ResistanceWealth Building Stock Market Ideas Based on Momentum - beatles.ru
How did Genprex's cost-cutting measures impact Q4 2024 profitability? - AInvest
Ichimoku Cloud Indicates Uncertainty Around Genprex Inc.Investment Playbook for Growing Markets Shared - metal.it
Genprex Inc. Hits Oversold Level on RSI IndicatorEarnings Play Trade Plan With Alerts Shared - metal.it
How volatile is Genprex Inc. stock compared to the marketBreakneck growth rates - jammulinksnews.com
How many analysts rate Genprex Inc. as a “Buy”Build a diversified portfolio for stability - jammulinksnews.com
What institutional investors are buying Genprex Inc. stockAchieve breakthrough investment performance - jammulinksnews.com
Is Genprex Inc. a growth stock or a value stockInvest confidently with real-time market updates - jammulinksnews.com
Published on: 2025-07-27 22:58:22 - jammulinksnews.com
What catalysts could drive Genprex Inc. stock higher in 2025Free Investment Community - jammulinksnews.com
Published on: 2025-07-27 19:14:53 - jammulinksnews.com
How Genprex Inc. stock performs during market volatilityLong Term Secure Gain Stocks - Newser
What drives Genprex Inc. stock priceFree Expert Stock Watchlist - PrintWeekIndia
Genprex Inc. Stock Analysis and ForecastMarket-beating performance - PrintWeekIndia
What analysts say about Genprex Inc. stockExponentially increasing returns - Autocar Professional
Genprex Inc Stock (GNPX) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.93%
0.15%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):